论文部分内容阅读
目的探讨应用醒脑静注射液治疗急性重症脑血管病的临床效果。方法 66例急性重症脑血管病患者,随机分为对照组和观察组,各33例。对照组行常规西药疗法,观察组在对照组的基础上加用醒脑静注射液,对比两组临床效果与不良反应发生情况。结果观察组总有效率为90.1%,对照组治疗总有效率为72.7%,两组对比差异有统计学意义(P<0.05)。观察组无不良反应现象,对照组不良反应发生率为9.1%,两组对比差异有统计学意义(P<0.05)。结论应用醒脑静注射液治疗急性重症脑血管病患者临床效果明显,且可降低不良反应发生率,值得推广应用。
Objective To investigate the clinical effect of Xingnaojing injection in the treatment of acute severe cerebrovascular disease. Methods Sixty-six patients with acute severe cerebrovascular disease were randomly divided into control group and observation group, with 33 cases in each group. The control group received conventional western medicine. The observation group was given Xingnaojing injection on the basis of the control group, and the clinical effects and adverse reactions of the two groups were compared. Results The total effective rate was 90.1% in the observation group and 72.7% in the control group, the difference between the two groups was statistically significant (P <0.05). There was no adverse reaction in the observation group. The incidence of adverse reactions in the control group was 9.1%, with significant difference between the two groups (P <0.05). Conclusion Xingnaojing injection in patients with acute severe cerebrovascular disease clinical effect is obvious, and can reduce the incidence of adverse reactions, it is worth promoting the application.